- Patent Title: Microporous zirconium silicate for the treatment of hyperkalemia
-
Application No.: US15878120Application Date: 2018-01-23
-
Publication No.: US10695365B2Publication Date: 2020-06-30
- Inventor: Donald Jeffrey Keyser , Alvaro F. Guillem
- Applicant: ZS PHARMA, INC.
- Applicant Address: US TX Coppell
- Assignee: ZS PHARMA, INC.
- Current Assignee: ZS PHARMA, INC.
- Current Assignee Address: US TX Coppell
- Agency: Culhane Meadows PLLC
- Agent Jeff B. Vockrodt
- Main IPC: A61K33/24
- IPC: A61K33/24 ; A61K33/00 ; A61K9/14 ; C07F7/02 ; C01B39/00 ; C01B33/20 ; A61K9/10 ; A61K45/06 ; B01J39/02 ; B01J19/00 ; B01J39/14 ; B01J19/18

Abstract:
The present invention relates to novel microporous zirconium silicate compositions that are formulated to remove toxins, e.g. potassium ions, from the gastrointestinal tract at an elevated rate without causing undesirable side effects. The preferred formulations are designed avoid increase in pH of urine in patients and/or avoid potential entry of particles into the bloodstream of the patient. Also disclosed is a method for preparing high purity crystals of ZS-9 exhibiting an enhanced level of potassium exchange capacity. These compositions are particularly useful in the therapeutic treatment of hyperkalemia.
Public/Granted literature
- US20180214479A1 MICROPOROUS ZIRCONIUM SILICATE FOR THE TREATMENT OF HYPERKALEMIA Public/Granted day:2018-08-02
Information query